Skip to main content
Clinical Trials/ACTRN12623001318673
ACTRN12623001318673
Not yet recruiting
未知

Automated vital sign monitoring devices in acutely unwell general medical inpatients: an exploratory study

Fisher & Paykel Healthcare Limited0 sites27 target enrollmentDecember 15, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Impaired respiratory function
Sponsor
Fisher & Paykel Healthcare Limited
Enrollment
27
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 15, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients admitted under a medical team \<24 hours
  • Anticipated to remain an inpatient in Wellington hospital for \>24 hours
  • EWS \=/\> 4 at time of eligibility assessment

Exclusion Criteria

  • Planned surgical intervention requiring transfer to an operating theatre within 24 hours
  • Cardiac pacemaker
  • Primarily receiving end of life care (Goals of Care D)
  • HDB/ICU admissions
  • Invasive/non\-invasive ventilation
  • Imminent need for ICU admission (currently planning for ICU admission)
  • Meeting MET call criteria at eligibility assessment (EWS \=/\>10 or any parameter in ‘blue zone’)
  • Practical reasons that a chest wall sensing device cannot be applied (MRI scanner, skin disease, dressings, etc.)
  • Cognitive impairment or impaired consciousness precluding informed consent and ability to co\-operate with application of continuous monitoring devices
  • Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials